Third, assessing the effects of PACAP administration on peripheral polyneuropathy in vivo presents a considerable challenge due to the ubiquitous expression of PACAP receptors, notably the PAC1 receptor, across various tissues, which can lead to systemic effects irrespective of central or peripheral localization [61,62,63,64]. The gene discussed is ADCYAP1R1; the disease is polyneuropathy.